HOXA1 3′UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma
Authors:
- Bruna Pereira SorrocheBSBruna Pereira Sorroche
- Keila Cristina MirandaKMKeila Cristina Miranda
- Caroline Moraes BeltramiCBCaroline Moraes Beltrami
- Lidia Maria Rebolho Batista ArantesLALidia Maria Rebolho Batista Arantes
- Luiz Paulo KowalskiLKLuiz Paulo Kowalski
- Fabio Albuquerque MarchiFMFabio Albuquerque Marchi
- Silvia Regina RogattoSRSilvia Regina Rogatto
- Janete Dias AlmeidaJAJanete Dias Almeida
Open Access
Abstract
Background: HOXA1 is a prognostic marker and a potential predictive biomarker for radioresistance in head and neck tumors. Its overexpression has been associated with promoter methylation and a worse prognosis in oral squamous cell carcinoma (OSCC) patients. However, opposite outcomes are also described. The effect of the methylation of this gene on different gene regions, other than the promoter, remains uncertain. We investigated the methylation profile at different genomic regions of HOXA1 in OSCC and correlated differentially methylated CpG sites with clinicopathological data. Methods: The HOXA1 DNA methylation status was evaluated by analyzing data from The Cancer Genome Atlas and three Gene Expression Omnibus datasets. Significant differentially methylated CpG sites were considered with a |∆β| ≥ 0.10 and a Bonferroni-corrected p-value < 0.01. Differentially methylated CpGs were validated by pyrosequencing using two independent cohorts of 15 and 47 OSCC patients, respectively. Results: Compared to normal tissues, we found significantly higher DNA methylation levels in the 3′UTR region of HOXA1 in OSCC. Higher methylation levels in tumor samples were positively correlated with smoking habits and patients’ overall survival. Conclusions: Our findings suggest that HOXA1 gene body methylation is a promising prognostic biomarker for OSCC with potential clinical applications in patient monitoring.Keywords
Funding Information
- São Paulo Research Foundation—FAPESP (#2016/08633-0)
This publication has 56 references indexed in Scilit:
- Occurrence of field cancerization in clinically normal oral mucosa: A systematic review and meta-analysisArchives of Oral Biology, 2022
- Molecular Insights into Oral MalignancyIndian Journal of Surgical Oncology, 2021
- Pan-cancer genomic analysis links 3’UTR DNA methylation with increased gene expression in T cellsEBioMedicine, 2019
- Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinomaArchives of Oral Biology, 2019
- Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinomaArchives of Oral Biology, 2019
- Surgical margins in head and neck cancer: Intra- and postoperative considerationsAuris Nasus Larynx, 2019
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatmentMedical Oncology, 2013
- Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongueHead & Neck, 2009
- Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinomaBritish Journal of Oral and Maxillofacial Surgery, 2007